Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
V VARIOUS
V03 ALL OTHER THERAPEUTIC PRODUCTS
V03A ALL OTHER THERAPEUTIC PRODUCTS
V03AB Antidotes
V03AB37 Idarucizumab
D10741 Idarucizumab (USAN/INN) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
33 Blood and body fluid agents
339 Miscellaneous
3399 Others
D10741 Idarucizumab (USAN/INN); Idarucizumab (genetical recombination) (JAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10741
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10741
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10741
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10741